NONINVASIVE DIAGNOSTICS BY SEQUENCING 5-HYDROXYMETHYLATED CELL-FREE DNA
First Claim
Patent Images
1. A method for sequencing hydroxymethylated cell-free DNA (cfDNA),(a) adding adaptor sequences onto the ends of cfDNA;
- (b) incubating the adaptor-ligated cfDNA with a DNA β
-glucosyltransferase and UDP glucose modified with a chemoselective group, thereby covalently labeling the hydroxymethylated DNA molecules in the cfDNA with the chemoselectivegroup;
(c) linking a biotin moiety to the chemoselectively-modified cfDNA via a cycloaddition reaction;
(d) enriching for the biotinylated DNA molecules by binding the product of step (c) to a support that binds to biotin;
(e) amplifying the enriched DNA using primers that bind to the adaptors; and
(f) sequencing the amplified DNA to produce a plurality of sequence reads, wherein the method does not comprise releasing the biotinylated DNA molecules from the support after step (d), prior to step (e).
3 Assignments
0 Petitions
Accused Products
Abstract
Provided herein is a method of sequencing hydroxymethyated cell-free DNA. In some embodiments, the method comprises adding an affinity tag to only hydroxymethyated DNA molecules in a sample of cfDNA, enriching for the DNA molecules that are tagged with the affinity tag; and sequencing the enriched DNA molecules.
-
Citations
29 Claims
-
1. A method for sequencing hydroxymethylated cell-free DNA (cfDNA),
(a) adding adaptor sequences onto the ends of cfDNA; -
(b) incubating the adaptor-ligated cfDNA with a DNA β
-glucosyltransferase and UDP glucose modified with a chemoselective group, thereby covalently labeling the hydroxymethylated DNA molecules in the cfDNA with the chemoselectivegroup;(c) linking a biotin moiety to the chemoselectively-modified cfDNA via a cycloaddition reaction; (d) enriching for the biotinylated DNA molecules by binding the product of step (c) to a support that binds to biotin; (e) amplifying the enriched DNA using primers that bind to the adaptors; and (f) sequencing the amplified DNA to produce a plurality of sequence reads, wherein the method does not comprise releasing the biotinylated DNA molecules from the support after step (d), prior to step (e).
-
-
2. A method of sample analysis, comprising:
-
(a) identifying hydroxymethylated sequences in a cell-free DNA (cfDNA) sample from a patient by; (i) ligating adaptor sequences to the cfDNA, (ii) modifying 5-hydroxymethylcytosine (5hmC) residues in the cfDNA to contain a capture tag;
(iii) enriching for cfDNA comprising hydroxymethylcytosine residues by linking the cfDNA to a support via the capture tag, thereby providing an enriched composition comprising support-bound hydroxymethylated cfDNA, (iv) amplifying the cfDNA molecules without releasing the hydroxymethylated cfDNA from the support, to provide amplified DNA, and (v) sequencing the amplified DNA to produce a plurality of sequence reads, and (vi) identifying hydroxymethylated sequences in the sequence reads;(b) comparing the identified hydroxymethylated sequences with a set of signature hydroxymethylation sequences that are correlated with a phenotype; and (c) providing a report indicating a correlation with the phenotype. - View Dependent Claims (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)
-
-
23. A kit for analyzing cfDNA, comprising:
-
DNA β
-glucosyltransferase;UDP glucose modified with a chemoselective group; an adaptor comprising at least one molecular barcode; and a spiked-in control comprising three amplicons synthesized from a cocktail of dATP, dGTP, dTTP, and (1) dCTP, (2) dmCTP, or (3) dhmCTP and dCTP. - View Dependent Claims (24)
-
-
25. A method for identifying sources of DNA in a cell-free DNA sample, comprising:
-
(a) providing a sample that comprises a pool of adaptor-ligated, cell-free DNA molecules that (i) have a molecular barcode to indicate their source, (ii) are hydroxymethylated, and (iii) linked to a support via a capture tag; (b) amplifying the cell-free DNA molecules without releasing the captured cell-free DNA from the support, to provide amplification products; (c) sequencing the amplification products to produce a plurality of sequence reads; and (d) identifying the sources of the cell-free DNA molecules from the molecular barcodes observed in the sequence reads. - View Dependent Claims (26, 27, 28, 29)
-
Specification